Results 101 to 110 of about 7,782 (210)

Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.

PLoS Neglected Tropical Diseases, 2015
BackgroundChagas disease is an anthropozoonosis caused by Trypanosoma cruzi. Two drugs are currently used for the etiological treatment of the disease: Nifurtimox (Lampit) and Benznidazole.
Fiorella Bianchi, Zulma Cucunubá, Felipe Guhl, Nadia Lorena González, Hector Freilij, Rubén Santiago Nicholls, Juan David Ramírez, Marleny Montilla, Astrid Carolina Flórez, Fernando Rosas, Victor Saavedra, Nubia Silva   +11 more
doaj   +1 more source

Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the Congo [PDF]

, 2017
Since 2009, nifurtimox-eflornithine combination therapy (NECT) has raised great hopes for the treatment of second-stage human African trypanosomiasis.
Alirol, Emilie, Amici Heradi, Josué, Chappuis, François, de Patoul, Catherine, Quere, Michel, Riedel, Andrea, Schrumpf, David   +6 more
core  

Efeito protetor do nifurtimox contra a reativação parasitária em pacientes cronicamente infectados pelo Trypanosoma cruzi e tratados com corticóide em virtude de afecções associadas

Revista da Sociedade Brasileira de Medicina Tropical, 1998
Pacientes na fase crônica da doença de Chagas foram tratados com corticóide em virtude de afecções associadas e, a fim de tentar coibir reativação da infecção pelo Trypanosoma cruzi, houve uso concomitante do nifurtimox.
Anis Rassi, Vicente Amato Neto, Astolpho Ferraz de Siqueira, Maurício Sérgio Brasil Leite   +3 more
doaj  

ISEV2025 Abstract Book

Journal of Extracellular Vesicles, Volume 14, Issue S1, October 2025.
wiley   +1 more source

Human African trypanosomiasis in endemic populations and travellers [PDF]

, 2018
Human African trypanosomiasis (HAT) or sleeping sickness is caused by the protozoan parasites Trypanosoma brucei (T.b.) gambiense (West African form) and T.b.
Blum, J., Hatz, C., Neumayr, A.
core  

Tratamento da fase crônica da doença de Chagas com nifurtimox associado a corticóide

Revista da Sociedade Brasileira de Medicina Tropical, 2002
Dez pacientes com doença de Chagas em fase crônica foram tratados durante 60 dias, com uma única exceção, por meio de nifurtimox (8 a 9mg/kg/dia) conjuntamente com betametasona (doses progressivamente decrescentes a partir de 9mg/dia).
Anis Rassi, Vicente Amato Neto, Astolpho Ferraz de Siqueira, Francisco Ferriolli Filho, Valdir Sabbaga Amato, Gustavo Gabriel Rassi, Anis Rassi Junior   +6 more
doaj  

Melarsoprol-Free Drug Combinations for Second-Stage Gambian Sleeping Sickness: The Way to Go. [PDF]

, 2007
Balasegaram, Brun, F. Chappuis, Priotto, P  pin, P  pin, Van Nieuwenhove   +6 more
core   +2 more sources

A Expressão Global da Doença de Chagas – Oportunidades Emergentes e Impacto em Portugal [PDF]

, 2012
Chagas disease, caused by the protozoan Trypanosoma cruzi is endemic in the countries of Central and South America. Despite vector control programs and other measures taken in the blood banks and maternity hospitals, it is estimated that there are about ...
Cortez, J, Ramos, E, Seixas, J, Valente, C, Vieira, A   +4 more
core  

Genotoxicity testing of antiparasitic nitrofurans in the Drosophila wing somatic mutation and recombination test [PDF]

, 2017
Nifurtimox and eight structurally related 5-nitrofuran compounds active against Trypanosoma cruzi were tested for genotoxicity in the wing somatic mutation and recombination test in Drosophila melanogaster.
Graf, Ulrich, Moraga, Angeles Alonso
core  

Pediatric Chagas disease. [PDF]

CMAJ
Garcia-Bournissen F, Cruz C, Altcheh J.
europepmc   +1 more source